Tc-99m-HMPAO labelled human platelets: in vitro and in vivo results.
The lipophilic 99mTc-HMPAO complex can be used for labelling platelets as well as granulocytes. Platelets were isolated according to standard isolation procedures for the evaluation of the optimal labelling parameters. The labelling efficiency (%) depends on incubation temperature (22 degrees C: 40%: 37 degrees C: 50%), incubation time (3 min: 20%, 25 min: 55%) and the incubation medium (plasma: 40%; saline 50%). The 60 min 99mTc elution out of the platelets ranged around 8%. The platelet recovery used as a quality control parameter is around 25% +/- 4% and is stable for at least 240 min. The high elution rate out of the platelets leads to renal excretion of the label and hence to significant kidney and bladder activity. Intestinal excretion of the label can also be frequently demonstrated. Fresh thrombotic lesions can normally be detected 4 h after reinjection of the labelled platelets, and in some patients as early as 1 h after reinjection. In conclusion, 99mTc-HMPAO seems to be a promising platelet label for imaging thrombotic lesions but not for platelet survival studies, because of the short physical half life of 99mTc.
Clinic and Policlinic of Nuclear Medicine, University Würzburg, Federal Republic of Germany.
W
W
Becker
U
U
Borst
T
T
Krahe
W
W
Börner
D001792:Blood Platelets; D002470:Cell Survival; D005260:Female; D006207:Half-Life; D006801:Humans; D066298:In Vitro Techniques; D007553:Isotope Labeling; D008297:Male; D009942:Organometallic Compounds; D010091:Oximes; D011877:Radionuclide Imaging; D013667:Technetium; D019690:Technetium Tc 99m Exametazime; D013927:Thrombosis / Q000000981:diagnostic imaging*
D009942:Organometallic Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D013667:Technetium